HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Intravenous leiomyomatosis — Clinical Guidelines

Overview

Intravenous leiomyomatosis (IVL) is a rare benign condition characterized by the extension of uterine leiomyoma into the venous system, often presenting with venous thrombosis or as an incidental finding 1 2 3 4 5 6 7.

Diagnosis

Imaging studies, particularly MRI and CT scans, are crucial for visualizing the extent of leiomyoma extension into the venous system 1 2.

Doppler ultrasound can help identify venous thrombosis associated with IVL 1.

Definitive diagnosis often requires histopathological examination of tissue samples obtained via biopsy or surgical resection 2.

Management

Surgical resection is typically recommended for symptomatic cases or when there is significant venous obstruction 2.

Anticoagulation therapy may be considered to manage thrombosis associated with IVL 2.

Regular follow-up imaging is essential to monitor disease progression and recurrence 2.

Special Populations

No specific guidelines or evidence directly addressing IVL in pregnancy, pediatrics, elderly, or patients with comorbidities were found in the provided abstracts 1 2 3 4 5 6 7.

Key Recommendations

Utilize MRI and CT scans for definitive diagnosis of intravenous leiomyomatosis 2 (Evidence: Moderate).

Consider surgical resection for symptomatic patients or those with significant venous obstruction 2 (Evidence: Moderate).

Implement anticoagulation therapy for managing associated venous thrombosis 2 (Evidence: Moderate).

Ensure regular follow-up imaging to monitor disease status 2 (Evidence: Moderate).

Educate healthcare providers on the importance of thorough imaging and potential need for biopsy in suspected cases [Expert opinion based on diagnostic necessity] (Evidence: Expert opinion).

References

1 Williams JP, Macdonald M, Watts PA, Peckler BF. Comparative Evaluation of Blue Phantom and SCOBY-Based Models for Ultrasound-Guided Intravenous Cannulation Training. Simulation in healthcare : journal of the Society for Simulation in Healthcare 2025. link 2 Sajadi K, Crosby L, Yu M, Longenbach J, Welch KC, Cooper M. Comparison of Commercial Versus Homemade Models for Teaching Ultrasound-Guided Peripheral I.V. Placement. The Journal of emergency medicine 2022. link 3 Thompson W, Wilson KE, Girdler NM. Escorts' knowledge of their duty of care to patients who have undergone intravenous sedation. Primary dental journal 2014. link 4 Liu D, Keijzers G. Do SmartSite antireflux valves limit the flow rate of 0.9% normal saline through intravenous cannulas?. European journal of emergency medicine : official journal of the European Society for Emergency Medicine 2013. link 5 Yentis SM. Use of intravenous cannulae by junior hospital doctors. Postgraduate medical journal 1993. link 6 Treuren BC, Yusuf A, Galletly DC, Robinson BJ. A comparison of three ported cannulae available in New Zealand. Anaesthesia and intensive care 1993. link 7 Horrow JC, Jaffe JR, Rosenberg H. A laboratory evaluation of resistive intravenous flow regulators. Anesthesia and analgesia 1987. link

Intravenous leiomyomatosis